MX387005B - Nanocápsula para la administración de un compuesto lipófilo y proceso de preparación de la misma. - Google Patents

Nanocápsula para la administración de un compuesto lipófilo y proceso de preparación de la misma.

Info

Publication number
MX387005B
MX387005B MX2018000637A MX2018000637A MX387005B MX 387005 B MX387005 B MX 387005B MX 2018000637 A MX2018000637 A MX 2018000637A MX 2018000637 A MX2018000637 A MX 2018000637A MX 387005 B MX387005 B MX 387005B
Authority
MX
Mexico
Prior art keywords
nanocapsule
administration
preparation process
lipophilic compound
î1⁄4m
Prior art date
Application number
MX2018000637A
Other languages
English (en)
Spanish (es)
Other versions
MX2018000637A (es
Inventor
Joanna Szafraniec
Szczepan Zapotoczny
Original Assignee
Univ Jagiellonski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Jagiellonski filed Critical Univ Jagiellonski
Publication of MX2018000637A publication Critical patent/MX2018000637A/es
Publication of MX387005B publication Critical patent/MX387005B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5176—Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MX2018000637A 2015-07-17 2016-07-12 Nanocápsula para la administración de un compuesto lipófilo y proceso de preparación de la misma. MX387005B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL413155A PL229276B1 (pl) 2015-07-17 2015-07-17 Nanokapsuła do przenoszenia związku lipofilowego i sposób jej wytwarzania
PCT/PL2016/050032 WO2017014655A1 (en) 2015-07-17 2016-07-12 Nanocapsule for delivery of lipophilic compound and process of preparation thereof

Publications (2)

Publication Number Publication Date
MX2018000637A MX2018000637A (es) 2018-09-06
MX387005B true MX387005B (es) 2025-03-12

Family

ID=56801756

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018000637A MX387005B (es) 2015-07-17 2016-07-12 Nanocápsula para la administración de un compuesto lipófilo y proceso de preparación de la misma.

Country Status (11)

Country Link
US (2) US10821083B2 (enExample)
EP (1) EP3324939A1 (enExample)
JP (1) JP6971217B2 (enExample)
KR (1) KR20180025318A (enExample)
CN (1) CN107847441B (enExample)
AU (3) AU2016295949A1 (enExample)
CA (1) CA2992705A1 (enExample)
MX (1) MX387005B (enExample)
PL (1) PL229276B1 (enExample)
RU (1) RU2723374C1 (enExample)
WO (1) WO2017014655A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018176047A (ja) * 2017-04-10 2018-11-15 パナソニックＩｐマネジメント株式会社 マイクロカプセル及びマイクロカプセルの製造方法、並びに、化粧料及び化粧料の製造方法
CN109535430A (zh) * 2017-09-22 2019-03-29 天津大学 一种油酰化壳寡糖胍接枝聚乙烯亚胺的两亲性衍生物及其制备方法
ES2711669A1 (es) * 2017-11-02 2019-05-06 Univ Santiago Compostela Sistemas de liberacion de farmacos de acido polisialico y metodos
CN108246215B (zh) * 2017-12-21 2020-06-30 四川大学 一种超薄壁壳聚糖微囊及其制备方法
PL240632B1 (pl) * 2018-04-06 2022-05-09 Univ Jagiellonski Zastosowanie nanokapsuły z ciekłym rdzeniem olejowym w terapii przeciwnowotworowej
CN108739807B (zh) * 2018-06-21 2021-07-13 中国热带农业科学院农产品加工研究所 植物油酸-壳聚糖基纳米微胶囊农药、其制备方法及其应用
CN112888428A (zh) * 2018-08-17 2021-06-01 克里兹托夫·斯梅拉 包封亲脂和亲水性化合物的纳米胶囊包纳米胶囊型的多隔室体系及相关生产方法
CN109925983B (zh) * 2019-03-08 2021-12-28 紫罗兰家纺科技股份有限公司 基于乳木果油的双层微胶囊及其整理到纺织面料中的方法
CN111920782B (zh) * 2019-05-13 2025-11-18 中国医学科学院药物研究所 复合脂质纳米囊组合物及其制备方法和应用
CN112300767B (zh) * 2020-09-22 2022-04-05 山东大学 一种绿色靶向微胶囊及制备体系、制备方法和应用
EP4321175B1 (en) 2022-08-11 2025-07-16 CHDE Polska S.A. Magnetic polymer nanocapsules suitable for use in therapy, especially anti-cancer ones
PL446441A1 (pl) * 2023-10-20 2025-04-22 Chde Polska Spółka Akcyjna 2-metylo-3-fitylo-1,4-naftochinon do stosowania w leczeniu lub zapobieganiu chorób przebiegających z dysfunkcją śródbłonka naczyniowego

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2093562B1 (es) 1995-05-26 1997-07-01 Univ Santiago Compostela Estabilizacion de sistemas coloidales mediante formacion de complejos ionicos lipido-polisacarido.
US20060063676A1 (en) 2004-09-17 2006-03-23 Brigance Mickey R Method for enhancing deposition of an agrochemical
CA2618974C (en) 2005-08-09 2014-01-28 Nanobio Corporation Nanoemulsion compositions having anti-inflammatory activity
EP2026771B1 (en) * 2006-01-23 2009-10-21 Yissum Research Development Company Of The Hebrew University Of Jerusalem Microspheres comprising nanocapsules containing a lipophilic drug
ATE515260T1 (de) * 2006-03-13 2011-07-15 Advanced In Vitro Cell Technologies S L Stabile nanokapselsysteme für die verabreichung von wirkstoffen
EP2266546A1 (en) 2009-06-08 2010-12-29 Advancell Advanced in Vitro Cell Technologies,S.A. Process for the preparation of colloidal systems for the delivery of active compounds
CN102161729B (zh) * 2011-02-25 2013-01-16 上海交通大学 水溶性多糖与疏水性单体形成纳米粒子的制备方法
ES2366255B2 (es) 2011-06-27 2012-08-08 Universidade De Santiago De Compostela Nanocomposiciones sacarídicas para la liberación de vacunas.
RU2494728C1 (ru) 2012-08-16 2013-10-10 Федеральное государственное унитарное предприятие "Государственный научный центр "Научно-исследовательский институт органических полупродуктов и красителей" (ФГУП "ГНЦ "НИОПИК") Наноэмульсия, содержащая биологически активное вещество
CZ304654B6 (cs) * 2012-11-27 2014-08-20 Contipro Biotech S.R.O. Nanomicelární kompozice na bázi C6-C18-acylovaného hyaluronanu, způsob přípravy C6-C18-acylovaného hyaluronanu, způsob přípravy nanomicelární kompozice a stabilizované nanomicelární kompozice a použití
JP2016531112A (ja) 2013-07-25 2016-10-06 ネムコア メディカル イノベーションズ インコーポレイテッド 疎水性白金誘導体のナノエマルジョン

Also Published As

Publication number Publication date
WO2017014655A1 (en) 2017-01-26
MX2018000637A (es) 2018-09-06
CN107847441A (zh) 2018-03-27
AU2016295949A1 (en) 2018-02-01
PL413155A1 (pl) 2017-01-30
RU2723374C1 (ru) 2020-06-10
AU2024201288A1 (en) 2024-03-14
US20180200197A1 (en) 2018-07-19
EP3324939A1 (en) 2018-05-30
US20200345651A1 (en) 2020-11-05
PL229276B1 (pl) 2018-06-29
CA2992705A1 (en) 2017-01-26
CN107847441B (zh) 2021-08-13
AU2021240279A1 (en) 2021-10-28
US10821083B2 (en) 2020-11-03
JP2018523642A (ja) 2018-08-23
KR20180025318A (ko) 2018-03-08
HK1251154A1 (zh) 2019-01-25
JP6971217B2 (ja) 2021-11-24

Similar Documents

Publication Publication Date Title
MX387005B (es) Nanocápsula para la administración de un compuesto lipófilo y proceso de preparación de la misma.
MX2022014781A (es) Formulaciones de anticuerpos anti-pdl1.
CL2015000501A1 (es) Nanopartícula polimérica de finasterida y minoxidil, proceso de preparación, suspensión acuosa conteniendo la misma, composición farmacéutica, y su uso.
AR098168A1 (es) Formulación estable de insulina glulisina
CL2015000502A1 (es) Nanoparticula polimerica de finasterida, suspension acuosa conteniendo a la misma, composicion para tratamiento de alopecia, proceso de preparacion de dicha composicion, y su uso.
WO2017127835A3 (en) Aqueous formulations and methods of preparation and use thereof
MX373001B (es) Composición nutricional que tiene compuestos lipofílicos con solubilidad y biodisponibilidad mejoradas.
EA201890491A1 (ru) Концентраты суспензий на масляной основе с низким гравитационным разделением и низкой вязкостью
EP4327880A3 (en) Solid state form of ribociclib succinate
EA201992832A1 (ru) Подкожное введение adamts13
FR3005420B1 (fr) Procede de stabilisation de suspensions d'erythrocytes encapsulant un principe actif, suspensions obtenues.
CO2018002438A2 (es) Composiciones de micropartículas que comprenden saflufenacil
MX2017014698A (es) Suspension de microcapsulas.
AR106559A1 (es) Suspensión acuosa para administración oral y método para su preparación
WO2015155703A3 (en) Composition and method of producing nanoformulation of water insoluble bioactives in aqueous base
AR093689A1 (es) Una composicion para la preparacion de acido hialuronico reticulado viscoelastico, y acido hialuronico reticulado obtenido al usar la misma
EA201890477A1 (ru) Инкапсулированная композиция финголимода
RU2013131625A (ru) Способ получения частиц инкапсулированного жирорастворимой полимерной оболочкой унаби, обладающего супрамолекулярными свойствами
CL2017001480A1 (es) Método de filtración
BR112015032594A2 (pt) cápsulas de camada de barreira
MX389712B (es) Formulacion inyectable de una lactona macrociclica y levamisol.
CO2017000354A2 (es) Desmopresina estabilizada
BR112016000469A2 (pt) Uso de um composto, e, método para aumentar o ph de uma suspensão aquosa
RU2014109980A (ru) Способ получения частиц инкапсулированного в альгинате натрия ароматизатора "фейхоа", обладающего супрамолекулярными свойствами
RU2014115406A (ru) Применение 8-(трифторметил)бензо[f][1,2,3,4,5]пентатиепин-6-амина в качестве антидепрессанта